|
⚲
|
| Keyboard |
| Hassard James
✚
|
|
|---|---|
| CIK # | 0001799357 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001799357] | |
| 4 | [0001799357] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Hassard James | |
| Crinetics Pharmaceuticals Inc | |
| Arrowhead Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-07-05 | Option exercise | 15,000 | $19.73 | 295,950 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-07-05 | Sell | 15,000 | $44.08 | 661,200 |
|
Crinetics Pharmaceuticals Inc CRNX
Stock option (Right to Buy) · derivative
|
2024-07-05 | Option exercise | 15,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-06-21 | Sell | 15,000 | $44.66 | 669,900 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-06-21 | Option exercise | 15,000 | $19.73 | 295,950 |
|
Crinetics Pharmaceuticals Inc CRNX
Stock option (Right to Buy) · derivative
|
2024-06-21 | Option exercise | 15,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-03-18 | Tax withheld | 1,741 | $38.14 | 66,402 |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (right to buy) · derivative
|
2024-03-04 | Grant | 63,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-03-04 | Grant | 17,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (right to buy) · derivative
|
2023-03-01 | Grant | 65,250 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2023-03-01 | Grant | 14,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (right to buy) · derivative
|
2022-03-10 | Grant | 160,000 | $0.00 | |
|
Arrowhead Pharmaceuticals Inc ARWR
Common Stock
|
2021-06-22 | Sell | 3,625 | $89.22 | 323,422 |
|
Arrowhead Pharmaceuticals Inc ARWR
Common Stock
|
2021-01-07 | Sell | 15,625 | $75.00 | 1,171,875 |